Screening for new agonists against Alzheimer's disease

被引:50
|
作者
Zheng, Huiqin
Wei, Dong-Qing
Zhang, Rui
Wang, Chunfang
Wei, Huachun
Chou, Kuo-Chen
机构
[1] Shanghai Jiao Tong Univ, Coll Life Sci & Technol, Shanghai 200240, Peoples R China
[2] Tianjin Normal Univ, Inst Bioinformat & Drug Discovery, Tianjin 300074, Peoples R China
[3] Gordon Life Sci Inst, San Diego, CA 92130 USA
关键词
Alzheimer's disease; alpha; 7; receptor; GTS-21; pharmacophore alignment; docking; traditional chinese medicines database;
D O I
10.2174/157340607781745492
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To find new drug candidates for treating Alzheimer's disease, we used the similarity search technique and GTS-21 as a template to search the Traditional Chinese Medicines Database. The high-score molecules thus obtained were compared with the template through the flexible alignment. Those molecules which had good alignment with GTS-21 were selected for conducting the docking studies aimed at the alpha 7 nicotinic acetylcholine receptor. The CHARMM22 force field was taken to compute the partial charge and the TABU search was adopted to operate the docking process. The docking results thus obtained were used to compare with that of GTS-21. Those molecules which had better docking results than that of GTS-21 were singled out for further consideration. Finally, it was found through an in-depth structural analysis that Mol 7235 might be a promising candidate for further modification by experiments to make it become an effective drug for treating Alzheimer's disease.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 50 条
  • [31] In silico and Biological Screening of Phytochemicals against NMDA Receptor for Alzheimer's Disease Therapeutics
    Baviskar, Bhushan Arun
    Deore, Sharada Laxman
    Shende, Bhavana Ashok
    Khadabadi, Somshekhar
    Kide, Anjali Ashokrao
    PHARMACOGNOSY RESEARCH, 2024, 16 (02): : 244 - 253
  • [32] Screening of Potential Inhibitors against Flotillin-1 as Therapeutics for Alzheimer's Disease
    Chaudhary, Amit
    Mani, Ashutosh
    PHARMACOGNOSY MAGAZINE, 2020, 16 (69) : 274 - 281
  • [33] Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's Disease
    Clader, JW
    Wang, YG
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (26) : 3353 - 3361
  • [34] Impact of muscarinic agonists for successful therapy of Alzheimer's disease
    Fisher, A
    Brandeis, R
    Haring, R
    Bar-Ner, N
    Kliger-Spatz, M
    Natan, N
    Sonego, H
    Marcovitch, I
    Pittel, Z
    AGEING AND DEMENTIA CURRENT AND FUTURE CONCEPTS, 2002, : 189 - 202
  • [35] Therapeutic potential of nuclear receptor agonists in Alzheimer's disease
    Moutinho, Miguel
    Landreth, Gary E.
    JOURNAL OF LIPID RESEARCH, 2017, 58 (10) : 1937 - 1949
  • [36] Impact of muscarinic agonists for successful therapy of Alzheimer's disease
    Fisher, A
    Brandeis, R
    Haring, R
    Bar-Ner, N
    Kliger-Spatz, M
    Natan, N
    Sonego, H
    Marcovitch, I
    Pittel, Z
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2002, (62): : 189 - 202
  • [37] L-Norvaline, a new therapeutic agent against Alzheimer's disease
    Baruh Polis
    Kolluru D.Srikanth
    Vyacheslav Gurevich
    Hava Gil-Henn
    Abraham O.Samson
    Neural Regeneration Research, 2019, 14 (09) : 1562 - 1572
  • [38] Nanomedicine against Alzheimer's and Parkinson's Disease
    Tandon, Ankit
    Singh, Sangh J.
    Chaturvedi, Rajnish K.
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (12) : 1507 - 1545
  • [39] L-Norvaline, a new therapeutic agent against Alzheimer's disease
    Polis, Baruh
    Srikanth, Kolluru D.
    Gurevich, Vyacheslav
    Gil-Henn, Hava
    Samson, Abraham O.
    NEURAL REGENERATION RESEARCH, 2019, 14 (09) : 1562 - 1572
  • [40] Immunological bullets against Alzheimer's disease
    Maria Papatriantafyllou
    Nature Reviews Neuroscience, 2013, 14 : 4 - 4